Resources from the same session
Revisiting old friends: New clinical developments of MEKi/BRAFi/NRASi combinations
Presenter: Ryan Sullivan
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast
Bispecific T-Cell engagers (TCE) and fusion protein carriers: Ready for prime-time in melanoma?
Presenter: Omid Hamid
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast
Clinical data, NGS, (x)-omics et al.: What is the ideal mixture to identify and overcome primary resistance to immune-checkpoint inhibitors?
Presenter: Ines Pires da Silva
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast
Discussion
Presenter: All Speakers
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Omid Hamid
Session: What’s the future in melanoma therapy? Novel targets, new drugs, reinvented approaches
Resources:
Slides
Webcast